Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance

When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.